Potentiation of brain acetylcholine neurons by Kami-Untan-To (KUT) in aged mice: Implications for a possible antidementia drug

Phytomedicine

Volumn 7, Issue 4, 2000, Pages 253-258

  Wang, Q ^a   Iwasaki, K ^a   Suzuki, T ^a   Arai, H ^a   Ikarashi, Y ^b   Yabe, T ^c   Toriizuka, K ^c   Hanawa, T ^c   Yamada, H ^c   Sasaki, H ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Alzheimer's disease; Choline acetyltransferase; Dementia; Herb; Immunohistochemistry; Kami Untan To (KUT); Traditional Chinese medicine

Indexed keywords

ACETYLCHOLINE; HERBACEOUS AGENT; KAMI UNTAN TO; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC NERVE; CONTROLLED STUDY; DEMENTIA; DRUG ACTIVITY; HERBAL MEDICINE; HIPPOCAMPUS; MOUSE; NERVE POTENTIAL; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRIATE CORTEX; SURVIVAL;

ANIMALIA;

EID: 0033855066     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0944-7113(00)80041-0     Document Type: Article

References (22)

1. Bao, F., Arai, H., Matsushita, S., Higuchi H. and Sasaki, H.: Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain. Neuroreport 7: 1733-1739, 1996.
2. Bartus, R. T., Dean, R. L. I., Beer, B. and Lippa, A. S.: The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-417, 1982.
3. Dekker, J. A. M., Connor, D. J. and Thai, L. J.: The role of cholinergic projections from the nuclus basalis in memory. Neurosci. Biobehav. Rev. 15: 299-317, 1991.
4. Dekker, M. W. and Mcgauch, J. L.: The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7: 151-168, 1991.
5. Davis, P. and Maloney, A. J. F.: Selective loss of central cholinergic neurons in Alzheimer's disease: A disorder of cortical cholinergic enervation. Science 218: 1184-1190, 1983.
6. Farlow, M. R. and Evans, R. M.: Pharmacologic treatment of cognition in Alzheimer's dementia. Neurology 51: 36-44, 1998.
7. Ikarashi, Y., Maruyama, Y. and Stavinoba, W. B.: Study of the use of the microwave magnetic field for the rapid inactivation of brain enzymes. Japan. J. Pharmacol. 35: 371-387, 1984.
8. Giacobini, E. and Becker, R.: Present progress and future development in the therapy for Alzheimer's disease. In: Iqbal, K., Wisniewski, H. K. and Windblad, B.: Alzheimer's disease and related disorders. New York: Alan R Liss Inc. 1121-1154, 1989.
9. Glowinski, J. and Iverson, L. L.: Regional studies of catecholamines in the rat brain-1: The disposition of 3H-norepinephrine, 3H-dopamine and 3H-dopa in various regions of the brain. J. Neurochem. 13: 655-669, 1966.
10. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. Journal of the American statistical association 53: 457-481, 1958.
11. Lee, V. M.-Y., Cardan, M. J., Schlaepfer, W. W. and Trojianowski, J. Q.: Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats. J. Neurosci. 11: 3474-3488, 1987.
12. Meguro, K., Yamaguchi, S., Arai, H., Nakagawa, T., Doi, C., Yamada, M., Ikarashi, Y., Maruyama, Y. and Sasaki, H.: Nicotine improves cognitive disturbance in senescence-accelerated mice. Pharmacol. Biochem. Behav. 49: 769-772, 1994.
13. Maruyama, Y., Ikarashi, Y. and Blank, C. L.: Evaluation of various microwave instruments for rapid inactivation of brain enzymes. Biogenic Amines. 4: 55-71, 1987a.
14. Maruyama, Y., Ikarashi, Y. and Blank, C. L.: Recent developments in the determination of acetylcholine and choline. TIPS 8: 84-86, 1987b.
15. Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R. and Friedhof, L. T.: A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 50: 136-145, 1998.
16. Potter, P. E., Meek, J. L. and Neff, N. H.: Acetylcholine and choline in neuronal tissue measured by HPLC with electrochemical detection. J. Neurochem. 41: 188-194, 1983.
17. Schneider, L. S. and Farlow, M. R.: Predicting response to cholinesterase inhibitors in Alzheimer's disease: possible approaches. CNS Drugs 4: 114-124, 1995.
18. th Annual Meeting, Society for Neuroscience Abstract Vol. 25, 848.12, 1999.
19. Whitehouse, P. J., Price, D. L., Strube, R. G., Clerke, A. W., Coyle, J. T. and Delong, M. R.: Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1237-1239, 1982.
20. Yabe, T., Toriizuka, K. and Yamada, H.: Choline acetyltransferase activity enhancing effects of kami-untan-to (KUT) on basal forebrain cultured neurons and lesioned rats. Phytomedicine 2 (1): 41-46, 1995.
21. Yabe, T., Toriizuka, K. and Yamada, H.: Kami-untan-to (KUT) improves cholinergic deficits in aged rats. Phytomedicine 2 (3): 253-258, 1996.
22. Yabe, T., Iizuka, S., Komatsu, Y. and Yamada, H.: Enhance-ment of choline acetyltransferase activity and nerve growth factor secretion by Polygalae radix-extract containing active ingredients in Kami-untan-to. Phytomedicine 4 (3): 199-205, 1997.